Drug profile

The FDA adverse-event record for Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain

Name: Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

14 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain. See the species affected, top reactions, and outcomes below.

14
adverse-event reports: 0.0%
death-coded share: Cat
most-reported species: 8
Lethargy (see also Central nervous system depression in Neurological) - top reaction

Compiled by PlainBreed Editorial, Pet Health Editorial Team

Verify with FDA CVM →

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death Rate

Active Ingredients

Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain

Administration Routes

SubcutaneousUnknown

Species Affected

Cat 14

Most Affected Breeds

Domestic Shorthair 5

Siamese 2

Domestic Mediumhair 2

Bengal 1

Cat (unknown) 1

Domestic Longhair 1

Ragdoll 1

Persian 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 8

Not eating 6

Fever 5

Anorexia 4

Injection site pain 3

Vomiting 2

Adipsia 2

Not drinking 2

Limping 2

Injection site swelling 2

Hypotension 1

Anaphylaxis 1

Outcome Breakdown

Recovered/Normal

7 (50.0%)

Outcome Unknown

4 (28.6%)

Ongoing

3 (21.4%)

Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain Adverse Event Insights

14 reports name Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain; 0 recorded a death outcome (0.0% of reported events, not a population-level mortality rate). Active ingredient: Feline Calicivirus, 255 Strain,Feline Calicivirus, Dd1 Strain,Feline Panleukopenia Virus, Cu-4 Strain,Feline Viral Rhinotracheitis, 605 Strain. Administration routes: Subcutaneous, Unknown.

By species: Cat (14 reports). By breed: Domestic Shorthair (5), Siamese (2), Domestic Mediumhair (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in Neurological) (8), Not eating (6), Fever (5), Anorexia (4). Outcome, 14 coded reports: Recovered/Normal leads at 50.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.